A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer
- 27 November 2015
- journal article
- magnetic resonance-imaging
- Published by Springer Nature in La radiologia medica
- Vol. 121 (4) , 308-314
Abstract
Purpose To reduce acute hematologic toxicity (HT) in rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy by sparing the hematopoietical bone marrow (BM) indentified by magnetic resonance (MR). Materials and methods A total of 35 staged II/III rectal cancer patients were prospectively enrolled. MR images of pelvis were fused with the simulating CT images. Active BM indentified by MR was contoured as an organ at risk in the treatment plan. The neoadjuvant treatment regimen consisted of 50 Gy of radiation delivered in 25 fractions, 5 days per week, with concurrent daily capecitabine (1650 mg/m2/day, twice daily during RT course) and weekly oxiliplatin 50 mg/m2/qw. Multivariable linear regression model is used to test correlation between HT and dose-volume of BM. Results Thirty-one patients (88.6 %) had stage T3–4 disease, and 30 patients (85.7 %) had node-positive disease. The median age of cohort was 55 years (range 28–73 years). Only 9 (25.7 %), 6 (17.1 %), 1 (2.9 %) and 1 (2.9 %) experienced acute Grade 2–4 leukopenia, neutropenia, anemia and thrombocytopenia, respectively. Multivariable linear regression revealed increased BM-V5 was significantly associated with decreased WBC nadirs (p = 0.005), decreased ANC nadirs (p = 0.002), and decreased PLT nadirs (p = 0.017). No dose-volume parameters of BM were found to be related with decreased Hb. Conclusions The irradiated volume of pelvic BM identified by MR is associated with HT in rectal cancer patients undergoing neoadjuvant concurrent chemoradiotherapy.Keywords
Funding Information
- Beijing hope run special fund (LC2012B22)
This publication has 34 references indexed in Scilit:
- Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET ImagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal CancerJournal of Clinical Oncology, 2007
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006
- Incorporation of magnetic resonance imaging into intensity modulated whole-pelvic radiation therapy treatment planning to reduce the volume of pelvic bone marrow irradiatedInternational Congress Series, 2004
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- The paradoxes in patterns and mechanism of bone marrow regeneration after irradiation: 1. Different volumes and dosesRadiotherapy and Oncology, 1984
- The Distribution of Active Bone Marrow in the AdultPhysics in Medicine & Biology, 1961